International Conference on

Nuclear Medicine and Medical Applications (ICNMMA-27)

Conference Date

16th Feb - 17th Feb 2027

Conference Venue

Paris, France

Conference Mode

Hybrid Conference
Proudly organized by:- Science Leagues

"Join global experts in Nuclear Medicine and Medical Applications"

Registration Options

View all registration categories and choose the best fit.

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
SDG 16
SDG 16 Peace, Justice and Strong Institutions
SDG 17
SDG 17 Partnerships for the Goals
Track 01

Advancements in Nuclear Medicine Techniques

This track will explore the latest innovations in nuclear medicine, including novel imaging techniques and therapeutic applications. Emphasis will be placed on the integration of these advancements into clinical practice to enhance patient outcomes.

Track 02

Biotechnology in Medical Applications

This session will focus on the role of biotechnology in the development of new medical therapies and diagnostics. Participants will discuss cutting-edge biotechnological approaches and their implications for patient care.

Track 03

Computer Software Innovations in Healthcare

This track will examine the impact of software applications in the medical field, particularly in diagnostics and treatment planning. The session aims to highlight the role of artificial intelligence and machine learning in enhancing healthcare delivery.

Track 04

Radiopharmaceutical Development and Applications

This session will delve into the research and development of radiopharmaceuticals for diagnostic and therapeutic purposes. Discussions will include regulatory challenges and the future of radiopharmaceuticals in personalized medicine.

Track 05

Integration of Engineering in Medical Technologies

This track will focus on the intersection of engineering and medical technology, showcasing innovations that improve diagnostic and therapeutic devices. Participants will explore collaborative approaches between engineers and medical professionals.

Track 06

Clinical Applications of Molecular Imaging

This session will highlight the clinical relevance of molecular imaging techniques in diagnosing and monitoring diseases. Attendees will discuss case studies and the potential for these techniques to transform patient management.

Track 07

Ethical Considerations in Nuclear Medicine

This track will address the ethical implications of nuclear medicine practices, including patient consent and the use of radioactive materials. Participants will engage in discussions on balancing innovation with ethical responsibilities.

Track 08

Translational Research in Medical Science

This session will focus on the process of translating basic research findings into clinical applications in nuclear medicine. Discussions will include successful case studies and the challenges faced in bridging the gap between research and practice.

Track 09

Patient Safety and Quality Assurance in Nuclear Medicine

This track will explore strategies for ensuring patient safety and quality assurance in nuclear medicine procedures. Participants will discuss best practices and regulatory standards that govern the field.

Track 10

Future Trends in Nuclear Medicine

This session will examine emerging trends and future directions in nuclear medicine and medical applications. Attendees will explore potential breakthroughs and their implications for healthcare.

Track 11

Collaborative Approaches in Medical Research

This track will highlight the importance of interdisciplinary collaboration in advancing medical research. Participants will discuss successful partnerships between various fields, including medicine, engineering, and biotechnology.